% | $
Quotes you view appear here for quick access.

Abbott Laboratories Message Board

  • zdnews zdnews May 17, 1998 2:47 PM Flag

    News on anticancer drug

    Judah Folkman just told Reuter that TAP=-=a joint
    venture between Abbott and Takeda has a potential drug
    candidate which works on mice. This is the continuation of
    Angiogenesis story. This may head to phase I trial later this
    year or next year. For those of you who do not know
    about TAP, it is a joint venture between Japan's Takeda
    Pharmaceutical and Abbott. Abbott international funds the
    research in the joint venture and derives profit from the
    prodcut produced by TAP. TAP pretty much behaves like an
    independent entity, it is fairly tricky to account the
    contribution of TAP profit to Abbott's profit. Anyway, thought
    your guys would like to know. I stand partially
    corrected on the assertion that Abbott does not have a
    cancer drug candidate, however, Abbott itself still does
    not have a cancer drug candidate. Recently Abbott
    also has closed the antifungal program as well as a
    cancer research program. Hope the stock will go up a
    little on Monday on the news.

39.30+0.41(+1.05%)May 27 4:02 PMEDT